1. Preparation of Plasmid DNA, Needles, and Injection Dishes
2. Preparation of Embryos for Injection
3. Microinjection of Plasmid DNA
4. Culturing and Hatching of Embryos
Establishing transgenic Hydra lines
Feed transgenic hatchlings every 2-3 days with Artemia nauplii. Hatchlings sometimes do not eat for a day or two after hatching. Some new hatchlings will never eat, and thus will not survive. If the hatchling is transgenic in either the ectodermal (Figure 1A) or endodermal epithelial tissue, allow the animal to bud and collect the buds that have the most transgenic tissue (Figure 1B, C). Continue to do this with the new buds until a transgenic line is established with uniform expression of the transgene in either the ectodermal (Figure 1D) or endodermal epithelial lineage. Simultaneously, a second line can be established that does not contain the transgene but is otherwise genetically identical (Figure 1B). This line serves as a negative control for future experiments. If the transgenic tissue does not move into a bud, it is sometimes possible to cut the animal and allow it to regenerate such that the transgenic tissue will be in the new budding zone. However, if the transgenic tissue is too close to the extremities it will likely be lost as it is displaced during the normal growth of the animal. Often there is nothing that can be done in this case. In our hands, if the transgene is neutral (i.e., has no impact on biological function) we are able to establish a uniform epithelial line from approximately 30% of Hydra that hatch with epithelial transgenic tissue. The remaining 70% either die or the transgenic tissue is lost. An endodermal line is approximately 2-3 times as common as an ectodermal line. If a transgene is being used that disrupts biological function, this may have an impact on the feasibility of establishing a uniform line. In such cases, inducible promoters will be essential additions to the toolkit.
If the hatchling is transgenic in the interstitial lineage, allow the animal to bud and collect the hatchlings with an increasing number of transgenic cells in the interstitial lineage. Be aware that sometimes it is not immediately clear that an animal is transgenic in the interstitial lineage, especially if it is also transgenic in an epithelial lineage. It is highly unlikely that a line completely transgenic in the interstitial lineage will be established simply by budding. If it is required that the interstitial lineage be fully transgenic, this can be accomplished by cloning in aggregates from interstitial stem cell-depleted animals such that the entire lineage is established from a single transgenic stem cell7.
In cases where a tissue- or cell type-specific promoter is used to drive expression of a fluorescent protein, transgenic animals may not be evident initially. For example if a promoter that is active only in the tentacles is used and the initial patch of transgenic tissue is in the body column, no fluorescent cells will be seen in the hatchling. So all hatchlings need to be propagated to allow transgenic tissue to be displaced into the tentacles and become evident.
Figure 1. Establishing a transgenic line with uniform ectodermal epithelial expression of DsRed2. (A) A hatchling with chimeric expression of a DsRed2 transgene under control of an actin promoter in a patch of ectodermal epithelial cells. (B) A first-generation bud from the hatchling in panel A is now producing two new buds. The bud labeled with an asterisk has no transgenic tissue and was used as the founding animal for a control line that is genetically identical to the transgenic line, except for the presence of the transgene. (C) A second-generation bud produced from the Hydra in panel B. (D) An example of a polyp from the transgenic line that was established with DsRed2 expression throughout the ectoderm. Please click here to view a larger version of this figure.
AEP Hydra Strain | NA | NA | Email: Celina Juliano at celina.juliano@yale.edu or Hiroshi Shimizu bubuchin2006@yahoo.co.jp |
High Speed Maxi Kit | Qiagen | 12662 | |
100 x 15 mm Petri Dishes | BD Falcon | 351029 | |
75 x 50 mm Glass Microscope Slide | Sigma | CLS294775X50 | |
Microinjection Fish Mold | IBI Scientific | FM-600 | |
Borosilicate Glass with Filament | Sutter Instrument | BF100-50-10 | O.D.: 1.0 mm, I.D.: 0.50 mm, 10 cm length |
Flaming/Brown Micropipette Puller | Sutter Instrument | P-97 | |
Phenol Red | Sigma | P3532 | |
Jewelers Forceps, Durmont #5 | Sigma | F6521 | |
Scalpel Blade #15 | Fisher | 50-822-421 | |
Mineral oil | Sigma | M8410-500ML | |
Microinjector | Narishige | IM-9B | |
Magnetic Stand | Narishige | GJ-1 | |
Iron Plate | Narishige | IP | |
Joystick Micromanipulator | Narishige | MN-151 |
As a member of the phylum Cnidaria, the sister group to all bilaterians, Hydra can shed light on fundamental biological processes shared among multicellular animals. Hydra is used as a model for the study of regeneration, pattern formation, and stem cells. However, research efforts have been hampered by lack of a reliable method for gene perturbations to study molecular function. The development of transgenic methods has revitalized the study of Hydra biology1. Transgenic Hydra allow for the tracking of live cells, sorting to yield pure cell populations for biochemical analysis, manipulation of gene function by knockdown and over-expression, and analysis of promoter function. Plasmid DNA injected into early stage embryos randomly integrates into the genome early in development. This results in hatchlings that express transgenes in patches of tissue in one or more of the three lineages (ectodermal epithelial, endodermal epithelial, or interstitial). The success rate of obtaining a hatchling with transgenic tissue is between 10% and 20%. Asexual propagation of the transgenic hatchling is used to establish a uniformly transgenic line in a particular lineage. Generating transgenic Hydra is surprisingly simple and robust, and here we describe a protocol that can be easily implemented at low cost.
As a member of the phylum Cnidaria, the sister group to all bilaterians, Hydra can shed light on fundamental biological processes shared among multicellular animals. Hydra is used as a model for the study of regeneration, pattern formation, and stem cells. However, research efforts have been hampered by lack of a reliable method for gene perturbations to study molecular function. The development of transgenic methods has revitalized the study of Hydra biology1. Transgenic Hydra allow for the tracking of live cells, sorting to yield pure cell populations for biochemical analysis, manipulation of gene function by knockdown and over-expression, and analysis of promoter function. Plasmid DNA injected into early stage embryos randomly integrates into the genome early in development. This results in hatchlings that express transgenes in patches of tissue in one or more of the three lineages (ectodermal epithelial, endodermal epithelial, or interstitial). The success rate of obtaining a hatchling with transgenic tissue is between 10% and 20%. Asexual propagation of the transgenic hatchling is used to establish a uniformly transgenic line in a particular lineage. Generating transgenic Hydra is surprisingly simple and robust, and here we describe a protocol that can be easily implemented at low cost.
As a member of the phylum Cnidaria, the sister group to all bilaterians, Hydra can shed light on fundamental biological processes shared among multicellular animals. Hydra is used as a model for the study of regeneration, pattern formation, and stem cells. However, research efforts have been hampered by lack of a reliable method for gene perturbations to study molecular function. The development of transgenic methods has revitalized the study of Hydra biology1. Transgenic Hydra allow for the tracking of live cells, sorting to yield pure cell populations for biochemical analysis, manipulation of gene function by knockdown and over-expression, and analysis of promoter function. Plasmid DNA injected into early stage embryos randomly integrates into the genome early in development. This results in hatchlings that express transgenes in patches of tissue in one or more of the three lineages (ectodermal epithelial, endodermal epithelial, or interstitial). The success rate of obtaining a hatchling with transgenic tissue is between 10% and 20%. Asexual propagation of the transgenic hatchling is used to establish a uniformly transgenic line in a particular lineage. Generating transgenic Hydra is surprisingly simple and robust, and here we describe a protocol that can be easily implemented at low cost.